arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

4D Molecular Therapeutics, Inc.

FDMT Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$10.28
Today
as of Aug 5, 16:48 ET
Last 30 days -11.38% Jun 26 → Aug 05
$9.31 $10.38 $11.45 $12.53 $13.60 Jun 26 Jul 06 Jul 14 Jul 21 Jul 29 Aug 05
Open
$9.93
High
$10.02
Low
$8.55
Volume
$641,096
Avg Vol
$907,464
Mkt Cap
$527M
P/E (TTM)
Beta
52w High
$12.34
52w Low
$3.68
Div Yield
Shares Out
$52M

Recent Press Releases & News last 60 days · 1 item

Overview

52-week range
$3.68
$12
76% of range
Avg surprise (last 3)
-6.0%
Avg reaction (last 2)
-0.3%
50% positive
Latest IV / EM
300%
EM ±50.1% · $10 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.01$-0.82$-0.62$-0.43$-0.24 Actual $-0.77Actual $-0.24Actual $-0.66Actual $-0.63Actual $-0.79Actual $-0.86Est $-0.84Actual $-0.98Est $-0.88Actual $-1.01Actual $-1.01Est $-0.97 JunSepMarJunSepMar/2025Jun/2025SepMar/2026
Revenue vs Net Income Revenue Net income
$-69M$-51M$-33M$-15M$3M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.01 $-0.97 -4.1% -17.4% -4.7% earnings
Tue Sep 30, 2025Sep 2025 $-1.01 financials
Mon Aug 11, 2025Jun/2025 $-0.98 $-0.88 -11.4% earnings
Thu May 8, 2025Mar/2025 $-0.86 $-0.84 -2.4% +4.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.79 financials
Sun Jun 30, 2024Jun 2024 $-0.63 financials
Sun Mar 31, 2024Mar 2024 $-0.66 financials
Sat Sep 30, 2023Sep 2023 $-0.24 financials
Fri Jun 30, 2023Jun 2023 $-0.77 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Aug 10, 2026Jun/2026OTHER -$1.04-$0.98 -6.1%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$3M$14,000$3,000$5,000
Cost of revenue
Gross profit
Operating income$-74M$-61M$-59M$-54M$-51M$-42M
Net income$-69M$-57M$-55M$-48M$-44M$-35M
EPS (diluted)$-1.01$-1.01$-0.98$-0.86$-0.79$-0.63

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$72M$60M$49M$77M$134M$149M$188M$189M
Inventory
Total current assets$405M$413M$312M$303M$333M$435M$511M$553M
Total assets$513M$567M$424M$474M$516M$560M$604M$620M
Long-term debt
Total liabilities$61M$61M$55M$53M$46M$50M$51M$32M
Total equity$452M$506M$369M$421M$470M$511M$553M$588M

Implied volatility — last 90 days

59%119%179%239%299% Jun 08 — IV 136% · EM ±17.9%Jun 15 — IV 247% · EM ±17.9%Jun 19 — IV 167% · EM ±37.0%Jun 22 — IV 182% · EM ±37.9%Jun 23 — IV 62% · EM ±12.7%Jun 24 — IV 223% · EM ±44.8%Jun 25 — IV 222% · EM ±43.4%Jun 29 — IV 59% · EM ±10.5%Jun 30 — IV 105% · EM ±18.0%Jul 01 — IV 125% · EM ±20.9%Jul 02 — IV 76% · EM ±12.3%Jul 03 — IV 79% · EM ±12.3%Jul 20 — IV 228% · EM ±53.8%Jul 21 — IV 142% · EM ±33.0%Jul 22 — IV 100% · EM ±22.8%Jul 28 — IV 79% · EM ±16.2%Jul 29 — IV 75% · EM ±15.1%Jul 30 — IV 80% · EM ±15.6%Jul 31 — IV 264% · EM ±50.6%Aug 03 — IV 280% · EM ±49.6%Aug 04 — IV 283% · EM ±48.7%Aug 05 — IV 300% · EM ±50.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.